Flexible Endoscopes Market Size, Share | Report 2023-2032
The global flexible endoscopes market was valued at USD 8.96 billion in 2022 and it is predicted to surpass around USD 18.71 billion by 2032 with a CAGR of 7.64% from 2023 to 2032.
Key Pointers
Report Scope of the Flexible Endoscopes Market
| Report Coverage | Details |
| Market Size in 2022 | USD 8.96 billion |
| Revenue Forecast by 2032 | USD 18.71 billion |
| Growth rate from 2023 to 2032 | CAGR of 7.64% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Olympus Corporation; Ethicon Endo-surgery; LLC.; FUJIFILM Holdings Corporation; Stryker Corporation; Boston Scientific Corporation; Karl Storz GmbH & Co. KG.; Smith & Nephew Inc.; Richard Wolf GmbH; Medtronic Plc (Covidien); Ambu A/S; PENTAX Medical and Machida Endoscope Co., Ltd. |
The increasing use of minimally invasive surgical procedures has led to a growing demand for various types of endoscopes and endoscopy devices in surgical interventions, such as cystoscopy, bronchoscopy, arthroscopy, and laparoscopy. This shift towards minimally invasive surgeries over traditional surgeries is attributable to multiple reasons such as cost-effectiveness, higher patient satisfaction, shorter hospital stays, and fewer post-surgical complications.
The COVID-19 pandemic disrupted various industries worldwide including the medical sector, which experienced significant impacts such as disruptions in treatment procedures and healthcare services, as well as challenges with the supply chain of medical devices. The market was also affected, with a decrease in demand for new endoscopes due to a reduction in endoscopy services being offered in hospitals due to COVID-19-related emergencies on healthcare staff. In February 2021, according to an article published by the Guidelines for Robotic Flexible Endoscopy at the Time of COVID-19, endoscopic procedures were significantly reduced during the pandemic, and only urgent cases were considered.
The COVID-19 pandemic affected the demand for these endoscopes due to certain endoscopic procedures, such as respiratory endoscopy and gastrointestinal endoscopy, being considered aerosol-generating procedures for SARS-CoV-2 transmission. For instance, the American Association for Bronchology & Interventional Pulmonology updated its recommendations for using flexible bronchoscopes in COVID-19 patients. The updated recommendations indicated that bronchoscopy posed a substantial risk to patients and staff as an aerosol-generating procedure. As a result, bronchoscopy was not the preferred option for diagnosing COVID-19 and was only considered for intubated patients if upper respiratory samples were negative. These factors contributed to a decrease in demand for flexible endoscopes and impacted the studied market during the COVID-19 pandemic.
Furthermore, factors driving the market include an increase in the prevalence of chronic diseases affecting internal body systems, the advantages of flexible endoscopes compared to other devices, and growing awareness for early diagnosis of these conditions. Inflammatory bowel diseases (IBD), stomach & colon cancers, respiratory infections, and tumors, among others, require the use of these devices for diagnosis. As a result, the growth in the incidence of these diseases has led to an increase in demand for these flexible devices. For instance, in 2022, the American Cancer Society, Inc. estimated that there were about 26,380 new cases of stomach cancer (15,900 in men and 10,480 in women) in the U.S., as well as 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer.
The high incidence and prevalence of chronic diseases such as lung cancer and irritable bowel syndrome in the U.S. are driving the demand for the use of flexible endoscopes. For example, the American Lung Association estimated that 236,000 people in the U.S. were diagnosed with lung cancer in 2021, while the American College of Gastroenterology reports that 10-15% of adults suffer from irritable bowel syndrome symptoms in the country. Moreover, the advantages of flexible endoscopes over other types are also contributing to their increasing use, with optical fiber being particularly advantageous due to its ability to change direction and expand its scope of application.
Flexible Endoscopes Market Segmentations:
By Type
By End-use
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Flexible Endoscopes Market
5.1. COVID-19 Landscape: Flexible Endoscopes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Flexible Endoscopes Market, By Type
8.1. Flexible Endoscopes Market, by Type, 2023-2032
8.1.1. Laparoscopes
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Arthroscopes
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Ureteroscopes
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cystoscopes
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Gynecology Endoscopes
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Neuroendoscopes
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Bronchoscopes
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Hysteroscopes
8.1.8.1. Market Revenue and Forecast (2020-2032)
8.1.9. Laryngoscopes
8.1.9.1. Market Revenue and Forecast (2020-2032)
8.1.10. Sinuscopes
8.1.10.1. Market Revenue and Forecast (2020-2032)
8.1.11. Otoscopes
8.1.11.1. Market Revenue and Forecast (2020-2032)
8.1.12. Sigmoidoscopes
8.1.12.1. Market Revenue and Forecast (2020-2032)
8.1.13. Pharyngoscopes
8.1.13.1. Market Revenue and Forecast (2020-2032)
8.1.14. Duodenoscope
8.1.14.1. Market Revenue and Forecast (2020-2032)
8.1.15. Nasopharyngoscopes
8.1.15.1. Market Revenue and Forecast (2020-2032)
8.1.16. Rhinoscopes
8.1.16.1. Market Revenue and Forecast (2020-2032)
8.1.17. Colonoscopes
8.1.17.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Flexible Endoscopes Market, By End-use
9.1. Flexible Endoscopes Market, by End-use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Outpatient Facilities
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Flexible Endoscopes Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.2. Market Revenue and Forecast, by End-use (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.4.2. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 11. Company Profiles
11.1. Olympus Corporation
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Ethicon Endo-surgery; LLC.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. FUJIFILM Holdings Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Stryker Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Boston Scientific Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Karl Storz GmbH & Co. KG.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Smith & Nephew Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Richard Wolf GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Medtronic Plc (Covidien)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ambu A/S
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers